Also listed under Psoriasis, Spondylarthropathies
ClinicalTrials.gov term: Arthritis, Psoriatic
10 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 7 with minor changes only.
Primary endpoint(s) modified
Also in this update: Results posted: Sep 30, 2026; Trial completed
Terrence A BarrettNot applicable NCT04504136 Registry history of NCT04504136 on ClinicalTrials.gov (opens the registry)
Phase changed: not applicable → not specified
Bursa Yuksek Ihtisas Training and Research HospitalNot specified NCT07858591 Registry history of NCT07858591 on ClinicalTrials.gov (opens the registry)
Start date pushed from Nov 16, 2026 to Jan 1, 2027
Northwestern UniversityNot applicable NCT07865390 Registry history of NCT07865390 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Trial sites reduced: 123 → 120 locations
TakedaPhase 3 NCT06671496 Registry history of NCT06671496 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion pushed from Jan 15, 2027 to Sep 13, 2027
MoonLake Immunotherapeutics AGPhase 3 NCT06641089 Registry history of NCT06641089 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 5, 2024 to Oct 10, 2024
Bristol-Myers SquibbPhase 3 NCT04908202 Registry history of NCT04908202 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary and study completion moved earlier from Nov 2027 to Aug 2027
Eli Lilly and CompanyPhase 4 NCT06864026 Registry history of NCT06864026 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Feb 4, 2027 to May 28, 2026
MoonLake Immunotherapeutics AGPhase 3 NCT06641076 Registry history of NCT06641076 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioNot specified NCT06630715 Registry history of NCT06630715 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Global Healthy Living FoundationNot specified NCT05652608 Registry history of NCT05652608 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-10-09 | NCT07869134 Phase 2 Trial of FT2109 for the Treatment of Psoriatic Arthritis | Forward Therapeutics new | Phase 2 |
| 2026-10-05 | NCT07858591 Retinal Capillary Vessel Density and Foveal Avascular Zone Size in Patients With… | Bursa Yuksek Ihtisas Training and Research Hospital new | |
| 2026-08-19 | NCT07772544 Prevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility… | Sociedade Portuguesa de Reumatologia new | |
| 2026-07-22 | NCT07718815 HLA B Leader in Patients With Psoriatic Arthritis | Centre Hospitalier Universitaire, Amiens new |
| Phase 1 | 7 | |
| Phase 2 | 11 | |
| Phase 2/3 | 1 | |
| Phase 3 | 28 | |
| Phase 4 | 16 |
Janssen Research & Development, LLC (9) · AbbVie (5) · Diakonhjemmet Hospital (5) · Bristol-Myers Squibb (4) · Novartis Pharmaceuticals (4) · Takeda (4) · UCB Biopharma SRL (4) · University of California, San Diego (4) · Charite University, Berlin, Germany (3) · Chinese University of Hong Kong (3)